Cynosure Stock Price (NASDAQ:CYNO)

Add to My Stocks
$46.75 $2.9 (6.61%) CYNO stock closing price Jan 23, 2017 (Closing)
YOUR DAILY UPDATE ON
CYNO
Cynosure
23 JAN 2017
amigobulls logo
CYNO hand_up
CYNO vs S&P 500
Closing Price: Jan 23, 2017
CYNO
$46.75 ( 6.61%)
S&P 500
2265.2 ( -0.27%)
CYNO
52 Week Price Range
1 Year Return: 20.57%
Q3 Growth*
Excellent
Profitable ?
Yes
net image
2016 Q3 Net Profit
5%
PE Valuation
Expensive*
home image
Rating
CYNO AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Cynosure Snapshot Video

13 5 2

CYNO Stock Details

Prev Close* : $43.85
Market Cap:
$1.05B
Day Low: $46.7
52 Week Low: $32.90
Open: $48.55
Volume: 3547506
Day High: $49.65
52 Week High: $55.94
Dividend:
N/A

Latest Stock Market News

Latest Articles

Cynosure News - From Partners

CYNO Stockcharts

View CYNO PE ratio, PS ratio stocks charts and compare with peers.
CYNO Chart
Note: Compare Cynosure stock price history with the index and industry peers.

Cynosure Valuation

PE ratio
(price earnings ratio)
53.74
PS ratio (
price to sales ratio
)
2.66
PB ratio (
price to book ratio
)
2.62

Cynosure Returns

ROE
(return on equity)
5%

Cynosure Financial Ratios

Asset Turnover
0.75
Receivables Turnover
10
Debt to Equity
0.04

CYNO Industry Peers

Company Price Change (%)
Accelerate Diagnostics (AXDX)20.20.25 (1.22%)
Ldr Holding (LDRH)36.980 (0%)
Cutera (CUTR)18.50 (0%)
Syneron Medical (ELOS)8.70.15 (1.75%)
Zeltiq (ZLTQ)42.020.79 (1.92%)
Photomedex (PHMD)2.120.06 (2.75%)
Lumenis (LMNS)13.760 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cynosure (CYNO)46.752.9 (6.61%)
Integer Holdings (ITGR)311.4 (4.73%)
Pacific Biosciences Of California (PACB)4.750.19 (4.17%)
GenMark (GNMK)12.480.23 (1.88%)
Syneron Medical (ELOS)8.70.15 (1.75%)
MICROBOT MEDICL (MBOT)5.20.06 (1.17%)
Novadaq Technologies (NVDQ)6.470.07 (1.09%)
Top gainers from Medical Instruments industry
* As of Jan 23, 2017
CompanyPriceChange (%)
Neovasc (NVCN)1.470.16 (9.82%)
Mesa Labs (MLAB)116.563.05 (2.55%)
Exactech (EXAC)25.650.55 (2.1%)
Accuray (ARAY)5.10.1 (1.92%)
AngioDynamics (ANGO)16.560.28 (1.66%)
Mazor Robotics (MZOR)21.520.34 (1.56%)
Opko Health (OPK)8.520.12 (1.39%)
Top losers from Medical Instruments industry
* As of Jan 23, 2017

Cynosure Financial Statements

income statement20152014201320122011
Net Sales Or Revenues339.46M292.36M226.01M153.49M110.6M
Net Income15.8M31.33M-1.64M10.96M-2.9M
Total Operating Expense167.21M143.97M136.1M76.78M64.31M
view Cynosure, Inc. income statement
balance sheet20152014201320122011
Total Assets534.61M457.72M414.49M234.56M151.58M
Total Liabilities130.2M99.61M86.14M37.06M31.95M
Shareholders Equity404.4M358.11M328.35M197.5M119.62M
view Cynosure, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-4.11M-0.48M-4.07M-6.05M-1.32M
Net Cash From (Used By) Operating Activities37.72M42.1M3.37M14.61M6.17M
Increase (Decrease) In Prop Plant And Equipment-10.78M-15.77M21.74M-3.11M-0.9M
view Cynosure, Inc. cashflow statement

Cynosure, Inc. Stock News - Partner Headlines

Cynosure Stock Message Board

An investor needs to spend 43.85 to buy CYNO stock, as the closing Cynosure stock price is 43.85. Stock price or share price can be used to find the total market value of a company. Cynosure market cap stands at 1.05B as of 20 Jan, 2017. Cynosure valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy CYNO stock than sell it, then Cynosure stock price goes up. Conversely, if more investors wanted to sell CYNO stock than buy it, there would be greater supply than demand, and the stock price would fall. 299817 shares were traded with a closing stock price of 43.85 as of 20 Jan, 2017, as can be seen from Cynosure stock quote. One can view Cynosure stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Cynosure stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.